Publication | Open Access

Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis

BiochemistryMedicineDiabetesGlycobiologyChronic Kidney DiseaseDiabetic Kidney DiseaseDiabetes MellitusPharmacologyNephrologyExperimental Diabetic Nephropathy